Wunderlich Capital Managemnt’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.96M | Sell |
3,764
-47
| -1% | -$49.4K | 1.77% | 20 |
|
|
2024
Q1 | $3.67M | Sell |
3,811
-272
| -7% | -$262K | 1.65% | 24 |
|
|
2023
Q4 | $3.59M | Sell |
4,083
-137
| -3% | -$120K | 1.61% | 24 |
|
|
2023
Q3 | $3.47M | Sell |
4,220
-36
| -0.8% | -$29.6K | 1.71% | 19 |
|
|
2023
Q2 | $3.06M | Sell |
4,256
-39
| -0.9% | -$28K | 1.5% | 30 |
|
|
2023
Q1 | $3.53M | Sell |
4,295
-52
| -1% | -$42.7K | 1.84% | 16 |
|
|
2022
Q4 | $3.14M | Sell |
4,347
-120
| -3% | -$86.6K | 1.75% | 20 |
|
|
2022
Q3 | $3.08M | Buy |
4,467
+53
| +1% | +$36.5K | 1.97% | 14 |
|
|
2022
Q2 | $2.61M | Buy |
4,414
+15
| +0.3% | +$8.87K | 1.52% | 22 |
|
|
2022
Q1 | $3.07M | Sell |
4,399
-39
| -0.9% | -$27.2K | 1.45% | 23 |
|
|
2021
Q4 | $2.8M | Buy |
4,438
+46
| +1% | +$29.1K | 1.25% | 38 |
|
|
2021
Q3 | $2.66M | Buy |
4,392
+1
| +0% | +$605 | 1.28% | 35 |
|
|
2021
Q2 | $2.45M | Sell |
4,391
-8
| -0.2% | -$4.47K | 1.24% | 38 |
|
|
2021
Q1 | $2.08M | Sell |
4,399
-83
| -2% | -$39.3K | 1.14% | 48 |
|
|
2020
Q4 | $2.17M | Buy |
4,482
+24
| +0.5% | +$11.6K | 1.2% | 37 |
|
|
2020
Q3 | $2.5M | Sell |
4,458
-149
| -3% | -$83.4K | 1.54% | 21 |
|
|
2020
Q2 | $2.87M | Sell |
4,607
-192
| -4% | -$120K | 2.02% | 12 |
|
|
2020
Q1 | $2.34M | Sell |
4,799
-144
| -3% | -$70.3K | 1.93% | 12 |
|
|
2019
Q4 | $1.86M | Buy |
4,943
+21
| +0.4% | +$7.89K | 1.17% | 43 |
|
|
2019
Q3 | $1.37M | Buy |
4,922
+79
| +2% | +$21.9K | 0.94% | 62 |
|
|
2019
Q2 | $1.52M | Buy |
4,843
+219
| +5% | +$68.6K | 1.01% | 53 |
|
|
2019
Q1 | $1.9M | Buy |
4,624
+56
| +1% | +$23K | 1.32% | 27 |
|
|
2018
Q4 | $1.71M | Sell |
4,568
-11
| -0.2% | -$4.11K | 1.31% | 32 |
|
|
2018
Q3 | $1.85M | Sell |
4,579
-251
| -5% | -$101K | 1.31% | 32 |
|
|
2018
Q2 | $1.67M | Buy |
+4,830
| New | +$1.67M | 1.16% | 40 |
|